Home Products Cited in Publications Worldwide Synthesis of fluorinated triphenylphosphonium analogs that improve cancer cell selectivity and in vivo detection
STAR Protoc.,2023,4(3):102437.
Keyes, Robert F.; McAllister, Donna; Dwinell, Michael B.; Smith, Brian C.
DOI:10.1016/j.xpro.2023.102437 PMID:37552599
Triphenylphosphonium (TPP+) compounds like mito-metformin (MMe) target cancer cells by exploiting their hyperpolarized mitochondrial membrane potential. Here, we present a protocol for synthesizing TPP+ analogs with selectivity for mammalian cancer cells, reduced toxicity, and quantifiability using fluorine-19 NMR (19F-NMR). We describe steps for treating mammalian cells with mitochondria-targeted compounds, treating and preparing mouse tissue with these compounds, and 19F-NMR detection of MMe analogs in cells and tissue. TPP+-conjugated metformin analogs include para-methoxy (pMeO-MMe) and para-trifluoromethyl MMe (pCF3-MMe) and meta-trifluoromethyl MMe (mCF3-MMe).